This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Duane Reade Going Private in $700 Million LBO

Duane Reade (DRD - Get Report) agreed to be taken private at $17 a share in a $700 million leveraged buyout led by Oak Hill Capital.

Duane Reade's stock closed Monday at $15.22 but had traded in the mid-$18 range as recently as early September. The drugstore chain's shares have never recovered from the battering they received following a second-quarter 2002 earnings warning, prior to which they were fetching more than $30 each.

Buying out the publicly held stock will cost $415 million, with the remainder of the overall price tag covering assumed debt.

Robert M. Bass-founded Oak Hill will provide the buyout's equity financing while the debt portion is being arranged by Banc of America Securities. As is customary in leveraged buyouts, Duane Reade's upper management tier, including Chief Executive Anthony Cuti, will own an equity slice in the reorganized company.

"We are confident that this agreement delivers excellent value to our stockholders while allowing us to effectively confront near-term industry challenges by affording us a degree of flexibility that we would not have as a public company," Cuti said in a statement. "We believe the partnership with Oak Hill will provide an opportunity to investigate new avenues to improve the business, while maintaining our leadership position in the metro New York market."

Cuti said customers, employees and business associates should expect a "seamless transaction."

The buyout was approved by independent members of Duane Reade's board with Bear Stearns advising. The deal is still contingent on stockholder and regulatory approval and the receipt of financing.

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
SYM TRADE IT LAST %CHG
DRD $1.85 0.00%
AAPL $125.42 0.00%
FB $85.76 0.00%
GOOG $520.51 0.00%
TSLA $268.26 0.00%

Markets

DOW 17,619.51 +23.16 0.13%
S&P 500 2,063.11 +5.48 0.27%
NASDAQ 4,986.8670 +28.3990 0.57%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs